{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:39:29Z","timestamp":1772451569311,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ijantimicag.2023.106743","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:31:03Z","timestamp":1675287063000},"page":"106743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-5443","authenticated-orcid":false,"given":"Chris A.","family":"Gentry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9022-5363","authenticated-orcid":false,"suffix":"II","given":"Riley J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharanjeet K.","family":"Thind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian S.","family":"Kliewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106743_bib0001","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0003","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhin.2010.07.015","article-title":"Mortality in patients with methicillin-resistant Staphylococcus aureus bacteraemia, England 2004\u20132005","volume":"77","author":"Lamagni","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0006","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","article-title":"Pathogenicity and virulence of Staphylococcus aureus","volume":"12","author":"Cheung","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0007","article-title":"Antivirulence strategies for the treatment of Staphylococcus aureus infections: a mini review","volume":"11","author":"Ford","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0008","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/09537100802503368","article-title":"Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms","volume":"20","author":"Winning","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0009","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1160\/TH05-01-0020","article-title":"Clopidogrel inhibits platelet\u2013leukocyte adhesion and platelet-dependent leukocyte activation","volume":"94","author":"Evangelista","year":"2005","journal-title":"Thomb Haemost"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0010","doi-asserted-by":"crossref","first-page":"e22279","DOI":"10.1002\/jbt.22279","article-title":"Clopidogrel reduces lipopolysaccharide-induced inflammation and neutrophil-platelet aggregates in an experimental endotoxemic model","volume":"33","author":"Wang","year":"2019","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0011","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1016\/j.bmcl.2007.07.057","article-title":"From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis","volume":"17","author":"Springthorpe","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0012","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jamacardio.2019.1189","article-title":"Antibacterial activity of ticagrelor in conventional P2Y12 inhibitor dosages against antibiotic-resistant Gram-positive bacteria","volume":"4","author":"Lancellotti","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0013","doi-asserted-by":"crossref","first-page":"eabd6737","DOI":"10.1126\/scitranslmed.abd6737","article-title":"Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell\u2013Morell receptor to clear Staphylococcus aureus bacteremia","volume":"13","author":"Sun","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ehjcvp\/pvaa099","article-title":"Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections","volume":"8","author":"Butt","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0015","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ejim.2019.10.011","article-title":"Protective activity of ticagrelor against bacterial infection in acute myocardial infarction patients","volume":"70","author":"Rigatelli","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02117-21","article-title":"Impact of clopidogrel on clinical outcomes in patients with Staphylococcus aureus bacteremia: a national retrospective cohort study","volume":"66","author":"Caffrey","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0017","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0018","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3269","article-title":"Platelets: at the nexus of antimicrobial defence","volume":"12","author":"Yeaman","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0019","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4049\/jimmunol.1601178","article-title":"Platelets mediate host defense against Staphylococcus aureus through direct bactericidal activity and by enhancing macrophage activities","volume":"198","author":"Ali","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/jth.12795","article-title":"A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia","volume":"13","author":"Wuescher","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0021","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0022","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jacbts.2018.05.005","article-title":"Ticagrelor reduces thromboinflammatory markers in patients with pneumonia","volume":"3","author":"Sexton","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib0023","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/cid\/ciaa661","article-title":"Dabigatran and the risk of Staphylococcus aureus bacteremia: a nationwide cohort study","volume":"73","author":"Butt","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106743_bib24","article-title":"Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia","author":"Gentry","year":"2023","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:44:28Z","timestamp":1760377468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0924857923000316"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106743","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106743"}}